• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Smith & Nephew: Restructuring of orthopedic business will free up resources for BRIC markets

Smith & Nephew: Restructuring of orthopedic business will free up resources for BRIC markets

July 26, 2011 By MassDevice staff

SNN logo

British orthopedic giant Smith & Nephew plc (NYSE:SNN) is shuffling the deck in order to focus on higher growth markets in Brazil, Russia, India and China, according to a company spokesman.

Late yesterday news began trickling out that SNN would be combining its Memphis, Tenn.-based orthopedic reconstruction division and its Andover, Mass.-based endoscopy unit into a new unit called the Advanced Surgical Devices Division, to be led by SNN veteran Mike Frazzette. He will replace former orthopedic division president Joseph DeVivo, whose last day will be August 5, the same day the company is set to announce its quarterly earnings.

A company spokesman told MassDevice that the new division will focus on serving customers in more established markets in the U.S., Canada, Europe, Japan, Australia and New Zealand.

“In the last few years we have seen the markets around us change, some significantly,” SNN spokesman Joseph Metzger told MassDevice in an email. “Our established markets, especially in North America and Europe, are under pressure. At the same time emerging markets have huge potential. We are going to ensure we have a focused organization and allocate appropriate resources to seize these opportunities.”

Metzger said that the company will release more details in the coming weeks.

As part of the realignment the new Advanced Surgical Devices Division will market the company’s orthopedic and sports medicine products in the more established markets. It will also serve existing customers of the company’s orthopedic and endoscopic divisions.

Separately, the company will look to free up “additional resource and focus will be given to the emerging markets of China, India, Brazil and Russia and other international markets,” Metzger wrote.

During the first quarter, SNN said its international business grew 8 percent, compared to a 4 percent uptick in the U.S. and just 1 percent in the EU and United Kingdom. Together the orthopedic and endoscopy divisions made up about 90 percent of Smith & Nephew’s total U.S. sales during the first quarter and 78 percent of its $1.055 billion global sales in Q1.

Meanwhile, SNN said sales in Africa, Asia, Australasia & other Americas were $253 million.

SNN shares were up a hair to $53.95 in late-day trading on Wall Street.

Filed Under: Business/Financial News, Endoscopic, News Well, Orthopedics, Wall Street Beat Tagged With: Personnel Moves, Smith & Nephew

More recent news

  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy